Global Market for Human Milk Oligosaccharides Boosted by the Increasing Sales of Infant Nutrition Products

The growing demand for baby nutrition products is translating into higher sales of various infant formula ingredients including human milk oligosaccharide (HMO). Essential health benefits of milk oligosaccharides consumption such as inhibition of pathogen in infants and maintaining gut microbiota is driving its popularity among consumers. The global market for milk oligosaccharides is expected to surges at an impressive pace over the next couple of years. Nutritional and prebiotic attributes of human milk oligosaccharides aids in development of a healthy immune system in infants.  Moreover, the product also helps in restricting adhesion of foreign particles such as microbial pathogens to epithelial surfaces, hence improving gut colonization. A new report added to the repository of Market Research Reports Search Engine, titled, “Human Milk Oligosaccharides Market: Global Industry Analysis and Opportunity Assessment, 2017 – 2027” offers comprehensive information on the growth of the market.

Click here For Free Sample Report@ https://www.mrrse.com/sample/3316

For non-lactating mothers, human milk oligosaccharides in an apt alternative as it contains all the vital nutrients important for normal growth of infants.  By applying advanced fermentation and chemical synthesis processes, manufacturers are producing premium-grade HMO in order to meet the requirements of high nutrition value in infant formula ingredients. World Health Organization (WHO) has revealed that over the next 10 years the world population is estimated to grow by nearly one billion and by 2050, the total figure will surpass 9 billion. The aforementioned factors are likely to reflect favorably on the global sales of infant nutrition product in the forthcoming years.

Fucosyllactose will continue to be a Top Selling HMO Product 

Global sales of Fucosyllatose currently account for around 50% value share of the global human milk oligosaccharides market, while sialyllactose holds the second spot with an estimated market share of 28%. By the end of 2017, close to US$ 9 Mn worth fucosyllactose HMO is expected to be consumed globally. Meanwhile, consumption of sialyllactose HMO across the globe is likely to contribute US$ 5 Mn to the overall market value by the end of 2017 and this figure is projected to grow to US$ 20 Mn by 2027-end, expanding at a CAGR of 15.1% during the forecast period (2017-2027).

Among regions, the market for human milk oligosaccharides in Asia Pacific is expected to remain highly lucrative throughout the assessment period. This is primarily owing to the growing demand for infant formula in various countries in the region, including China and India.

Browse Full Report with TOC@ https://www.mrrse.com/human-milk-oligosaccharides-market

High-Cost of Chemical Synthesis and Availability of Similar Substitutes Remain Major Growth Deterrents of the Global HMOs market 

Human milk oligosaccharides content is significantly high in human milk, but due to lack of donor group, direct synthesis through human milk remains challenging. Manufacturers are currently focusing of development of technologies that facilitate the production of human milk oligosaccharides through enzymatic and chemical synthesis. However, such leading-edge methods incur hefty capital investment and do to not guarantee the best-quality product. For example, enzymatic synthesis is used for producing premium substrates such as glycosyltransferases, which is an extremely expensive human milk oligosaccharides product. 

Fructooligosaccharides and galactooligosaccharides are use as probiotic ingredients in the preparing infant formula. These ingredients help in keeping the gastrointestinal tract of infant healthy by stimulating the growth of certain micro-organisms present in intestinal microflora. Manufacturers are utilizing such ingredients as alternative to HMOs owing to their widespread availability and low-cost.

About (MRRSE)

Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords. 

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact       

State Tower
90, State Street
Suite 700
Albany, NY - 12207
United States Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website: https://www.mrrse.com/
Read More Industry News At: https://www.industrynewsanalysis.com/

This release was published on openPR.